To evaluate the in vivo efficacy of silencing IL-2/15Rβ for RA treatment, AA rats were intravenously injected with PEI/IL-2/15Rβ siRNA once per week for three weeks. The gene discussed is IL2; the disease is rheumatoid arthritis.